AMETEK Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Sales: Record $2.04 billion, up 15% year-over-year; organic sales increased by 10%.

Orders: Record $2.3 billion, up 28% year-over-year; organic orders rose 25%, leading to a backlog of $4.11 billion.

Operating Income: Record $544 million, an 18% increase; operating margins at 26.6%, up 60 basis points.

Core Operating Margins: 27.1%, up 110 basis points.

EBITDA: Record $644 million, up 14%; EBITDA margins at 31.5%.

Free Cash Flow: Increased by 37% to $452 million, with a conversion rate of 111% of net income.

Earnings Per Share: Record $2.09, up 17%, exceeding guidance of $1.96 to $2.00.

2Strategic Updates and Business Highlights

Electronic Instruments Group (EIG): Sales of $1.32 billion, up 14%; strong orders growth with organic orders up 20%. Key growth areas included process instrumentation and aerospace.

Electromechanical Group (EMG): Record sales of $723 million, up 17%; organic orders up 35%. Growth driven by aerospace, defense, MedTech, and automation sectors.

Acquisitions: Indicor Instrumentation acquisition expected to close in H2 2026, with integration planning underway. Anticipated synergies and strong recurring revenue streams.

Innovation: New product vitality at 25%, with notable launches like MicroFoil heat exchangers and A2GLF oxygen sensors.

3Forward Guidance and Outlook

2026 Sales Guidance: Now expected to increase by approximately 10%, with organic sales projected to grow mid- to high single digits.

Earnings Per Share Guidance: Revised to $8.20 to $8.30, reflecting a 10% to 12% increase compared to the previous year.

Q3 Expectations: Anticipated sales growth in high single digits; adjusted EPS forecast of $2.08 to $2.10.

4Bad News, Challenges, or Points of Concern

Market Sensitivity: The company operates in a volatile macroeconomic environment, with geopolitical uncertainties and fluctuating energy prices potentially impacting demand.

Capacity Utilization: While currently adequate, any significant increase in demand could strain existing capacity, although management indicated flexibility in scaling operations.

Acquisition Integration Risks: While Indicor is expected to enhance growth, integration challenges could pose risks if not managed effectively.

5Notable Q&A Insights

End Market Performance: Strong growth noted across semiconductor and MedTech sectors, with a diversified portfolio mitigating reliance on any single market.

Order Backlog: Backlog of $4.11 billion with a positive book-to-bill ratio of 1.12; 80% of backlog expected to ship within 12 months.

AI and Automation: AI initiatives are enhancing operational efficiency and product development, with ongoing projects expected to yield significant benefits.

Pricing Power: The company has successfully offset inflation and tariffs, indicating strong pricing power due to its differentiated product offerings.

Geographic Strength: Growth observed across all major regions, particularly in the U.S. and Asia, with strong demand in process and aerospace sectors. Overall, AMETEK reported a robust quarter with strong growth metrics, strategic positioning for future opportunities, and a positive outlook, despite some potential challenges in market volatility and integration risks.